Search Results - "Kinnucan, Jami A"

Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and Training by Bali, Aman S., Hashash, Jana G., Picco, Michael F., Kinnucan, Jami A., Farraye, Francis A.

“…Use of the electronic health record (EHR) has become increasingly widespread. Higher EHR burden is associated with burnout, but this has not been specifically…”
Get full text

Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination by Karime, Christian, Black, Cecily N., Cortes, Pedro, Kwon, Joshua Y., Caldera, Freddy, Crosby, Sheena K., Picco, Michael F., Kinnucan, Jami A., Hashash, Jana G., Farraye, Francis A.

“…INTRODUCTION: Hepatitis B virus (HBV) vaccination is recommended in patients with inflammatory bowel disease (IBD). Although the 2-dose Heplisav-B vaccine has…”
Get full text

Reassessing the Risks and Benefits of Thiopurines in Crohn's Disease by Kinnucan, Jami A., MD, Hanauer, Stephen B., MD, AGAF

Get full text

S1237 Efficacy of Upadactinib in the Management of Perianal Disease in Patients With Crohn’s Disease by Odah, Tarek, Kinnucan, Jami A., Picco, Michael F., Hashash, Jana G., Farraye, Francis A.

Get full text

Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease by Loeb, Lauren, Nasir, Ayan, Picco, Michael F, Hashash, Jana G, Kinnucan, Jami A, Farraye, Francis A

Get full text

Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study by Berinstein, Jeffrey A., Sheehan, Jessica L., Dias, Michael, Berinstein, Elliot M., Steiner, Calen A., Johnson, Laura A., Regal, Randolph E., Allen, John I., Cushing, Kelly C., Stidham, Ryan W., Bishu, Shrinivas, Kinnucan, Jami A.R., Cohen-Mekelburg, Shirley A., Waljee, Akbar K., Higgins, Peter D.R.

“…Despite rescue therapy, more than 30% of patients with acute severe ulcerative colitis (ASUC) require colectomy. Tofacitinib is a rapidly acting Janus kinase…”
Get full text

S1328 Histologic Serrated Epithelial Change and Superficial Hyperplastic Change Is Associated With Increased Risk of Dysplasia in Patients With Inflammatory Bowel Disease by Saleh, Hasan, Kinnucan, Jami A., Hashash, Jana G., Picco, Michael F., Farraye, Francis A., Odah, Tarek

Get full text

S1071 GLP-1 Agonist Use is Associated With Lower Complications and Mortality in Patients With Ulcerative Colitis and Obesity: A National Database Analysis by Nieto, Luis M., Narvaez, Sharon, Kim, Do Han, Ko, Donghyun, Chawla, Saurabh, Vega, Kenneth, Davisson, Laura, Kinnucan, Jami A.

Get full text

S1234 Patients With Crohn’s Disease and Ileostomy Can Achieve Remission With Upadacitinib by Loeb, Lauren P., Farraye, Francis A., Kinnucan, Jami A., Crosby, Sheena K., Picco, Michael F., Hashash, Jana G.

Get full text

Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis by Berinstein, Jeffrey A., Steiner, Calen A., Regal, Randolph E., Allen, John I., Kinnucan, Jami A.R., Stidham, Ryan W., Waljee, Akbar K., Bishu, Shrinivas, Aldrich, Leslie B., Higgins, Peter D.R.

“…As many as 25% of patients diagnosed with ulcerative colitis are hospitalized with an episode of acute severe ulcerative colitis (ASUC).1 The standard of care…”
Get full text

Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case–Control Study by Rubin, David T, Huo, Dezheng, Kinnucan, Jami A, Sedrak, Mina S, McCullom, Nicole E, Bunnag, Alana P, Raun–Royer, Elin P, Cohen, Russell D, Hanauer, Stephen B, Hart, John, Turner, Jerrold R

“…Background & Aims An association between inflammatory activity and colorectal neoplasia (CRN) has been documented in patients with ulcerative colitis (UC)…”
Get full text

Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib by Odah, Tarek, Karime, Christian, Desai, Aakash, Picco, Michael F., Kinnucan, Jami A., Hashash, Jana G., Farraye, Francis A.

“…Background and Aims Upadacitinib is an oral selective Janus kinase (JAK) inhibitor approved in the United States for ulcerative colitis (UC) and Crohn’s…”
Get full text

Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study by Petrov, Jessica C, Desai, Aakash A, Kochhar, Gursimran S, Crosby, Sheena K, Kinnucan, Jami A, Picco, Michael F, Hashash, Jana G, Farraye, Francis A

“…Metformin exerts anti-inflammatory properties through a positive effect on oxidative stress, gut barrier integrity, and the gut microbiota. Our aim was to…”
Get full text

Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program by Dubinsky, Marla C, Magro, Fernando, Steinwurz, Flavio, Hudesman, David P, Kinnucan, Jami A, Ungaro, Ryan C, Neurath, Markus F, Kulisek, Nicole, Paulissen, Jerome, Su, Chinyu, Ponce de Leon, Dario, Regueiro, Miguel

“…Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of ulcerative colitis (UC). These post hoc analyses assessed associations between…”
Get full text

Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation by Kinnucan, Jami A, Rubin, David T, Ali, Tauseef

“…Sleep disturbances are associated with a greater risk of serious adverse health events, economic consequences, and, most importantly, increased all-cause…”
Get full text

Resuscitating the Socratic Method: Student and Faculty Perspectives on Posing Probing Questions During Clinical Teaching by Abou-Hanna, Jacob J., Owens, Sonal T., Kinnucan, Jami A., Mian, Shahzad I., Kolars, Joseph C.

“…Teaching by way of asking questions is a time-honored practice that has taken on the negative connotation of "pimping" among medical students and has made some…”
Get full text

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program by Loftus, Edward V, Baumgart, Daniel C, Gecse, Krisztina, Kinnucan, Jami A, Connelly, Susan B, Salese, Leonardo, Su, Chinyu, Kwok, Kenneth K, Woolcott, John C, Armuzzi, Alessandro

“…Abstract Background Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Patients with inflammatory…”
Get full text

Nuances of the psychogastroenterology patient: A predictive model for gastrointestinal quality of life improvement by Riehl, Megan E., Kinnucan, Jami A., Chey, William D., Stidham, Ryan W.

“…Background Gastrointestinal conditions are multifactorial in nature, and certain patients can benefit greatly from brain–gut psychotherapies delivered by…”
Get full text

Tu1272 Psychological Characteristics and Daily Abdominal Pain but Not Disease Type or Severity Predicted Medical Cannabis Use in IBD by Kinnucan, Jami A, Nolan, Amanda A, Rubin, David T, Hanauer, Stephen B, Keefer, Laurie

Get full text

Vedolizumab is Safe and Effective for IBD, but has no Effect on Liver Biochemistry in Patients with Concurrent PSC by Christensen, Britt, Micic, Dejan, Gibson, Peter R, Singh, Samrath, Bellaguarda, Emanuelle, Corsello, Paul, Gaetano, John N, Kinnucan, Jami A, Rao, Vijaya L, Reddy, Shilpa, Yarur, Andres J, Rubin, David T, Pekow, Joel

Get full text